ProtoKinetix, Inc. (PK:PKTX)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for PKTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 24th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 15/24 Mar 29/24 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 2,500,000 $0.010
Apr 15/24 Mar 20/24 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 666,667 $0.015
Dec 28/23 Dec 26/23 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 7,333,334 $0.015
Oct 27/23 Oct 26/23 Guzzetta Michael Richard Direct Ownership Common Stock P - Open market or private purchase 20,000 $0.017
Aug 30/23 Aug 29/23 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 1,500,000 $0.020
Jun 15/23 Jun 15/23 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 2,000,000 $0.020
May 24/23 May 22/23 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 3,750,000 $0.020
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PKTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 24th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 15/24 Mar 29/24 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 2,500,000 $0.010
Apr 15/24 Mar 20/24 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 666,667 $0.015
Dec 28/23 Dec 26/23 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 7,333,334 $0.015
Oct 27/23 Oct 26/23 Guzzetta Michael Richard Direct Ownership Common Stock P - Open market or private purchase 20,000 $0.017
Aug 30/23 Aug 29/23 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 1,500,000 $0.020
Jun 15/23 Jun 15/23 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 2,000,000 $0.020
May 24/23 May 22/23 Smith Clarence Edward Direct Ownership Common Stock P - Open market or private purchase 3,750,000 $0.020
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $PKTX

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Disc Medicine (OQ:IRON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.